Cannabinoid receptors and their ligands.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Prostaglandins, Leukotrienes and Essential Fatty Acids

• Publication date

  2002-02-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1054/PLEF.2001.0341PMID 12052030
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cannabinoids and Multiple Sclerosis

  2007cited by this paper
• The fatty acid amide hydrolase (FAAH).

  2002cited by this paper
• Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells.

  2001influential reference
• Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.

  2001cited by this paper
• Δ9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study

  2001cited by this paper
• Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed.

  2001cited by this paper
• The Cannabinoid Agonist WIN55,212-2 Suppresses Opioid-induced Emesis in Ferrets

  2001cited by this paper
• Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids.

  2001cited by this paper
• Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis

  2001cited by this paper
• Delta9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study.

  2001cited by this paper
• Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro

  2001cited by this paper
• The vanilloid receptor (VR1)‐mediated effects of anandamide are potently enhanced by the cAMP‐dependent protein kinase

  2001cited by this paper
• Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

  2001cited by this paper
• Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens.

  2001cited by this paper
• Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase.

  2001cited by this paper
• Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens

  2001influential reference
• Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons

  2001influential reference
• 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

  2001cited by this paper
• Endocannabinoids control spasticity in a multiple sclerosis model

  2001influential reference
• Anandamide Excites Central Terminals of Dorsal Root Ganglion Neurons via Vanilloid Receptor-1 Activation

  2001cited by this paper
• Enhanced acetylcholine release in the hippocampus of cannabinoid CB1 receptor‐deficient mice

  2001cited by this paper
• The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan.

  2001cited by this paper
• Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord.

  2001cited by this paper
• Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.

  2001cited by this paper
• Inhibitory effects of SR141716A on G-protein activation in rat brain.

  2001cited by this paper
• Leptin-regulated endocannabinoids are involved in maintaining food intake

  2001cited by this paper
• Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

  2001influential reference
• The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study.

  2001cited by this paper
• Structure‐activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens

  2001cited by this paper
• Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line

  2001cited by this paper
• Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids.

  2001cited by this paper
• Cannabinoid receptors and pain.

  2001cited by this paper
• Differential effects of anandamide on acetylcholine release in the guinea‐pig ileum mediated via vanilloid and non‐CB1 cannabinoid receptors

  2001cited by this paper
• Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals.

  2001influential reference
• Orphan G protein-coupled receptors in the CNS.

  2001cited by this paper
• Ultrastructural Localization of the CB1 Cannabinoid Receptor in μ-Opioid Receptor Patches of the Rat Caudate Putamen Nucleus

  2001cited by this paper
• The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular Metabolism*

  2001cited by this paper
• Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.

  2001cited by this paper
• The neurobiology and evolution of cannabinoid signalling.

  2001cited by this paper
• Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease

  2001cited by this paper
• A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea‐pig bronchus

  2001cited by this paper
• Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

  2001cited by this paper
• Ceramide: a new second messenger of cannabinoid action.

  2001cited by this paper
• Cannabinoid inhibition of the capsaicin‐induced calcium response in rat dorsal root ganglion neurones

  2001cited by this paper
• CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.

  2001cited by this paper
• Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice

  2000cited by this paper
• Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Δ9-THC and anandamide1Published on the World Wide Web on 18 January 2000.1

  2000cited by this paper
• Localization of cannabinoid CB1 receptor mRNA in neuronal subpopulations of rat striatum: A double‐label in situ hybridization study

  2000cited by this paper
• Oxidative metabolism of anandamide.

  2000cited by this paper
• Cellular signal transduction by anandamide and 2-arachidonoylglycerol.

  2000influential reference
• Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain.

  2000cited by this paper
• Modulation of 3H‐noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and β‐adrenoceptors in mouse tissues

  2000cited by this paper
• Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland.

  2000cited by this paper
• Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.

  2000influential reference
• Functional expression of cell surface cannabinoid CB(1) receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons.

  2000cited by this paper
• Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.

  2000cited by this paper
• Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C‐terminal tail of CB1

  2000influential reference
• Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances.

  2000cited by this paper
• The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

  2000cited by this paper
• Induction of vanilloid receptor channel activity by protein kinase C

  2000cited by this paper
• Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata.

  2000cited by this paper
• Comparison of novel cannabinoid partial agonists and SR141716A in the guinea‐pig small intestine

  2000cited by this paper
• Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.

  2000cited by this paper
• D2 dopamine receptors enable Δ9‐tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration

  2000cited by this paper
• Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist/inverse agonist AM281

  2000cited by this paper
• The anandamide transport inhibitor AM404 is an agonist at the rat vanilloid receptor (VR1)

  2000cited by this paper
• Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.

  2000influential reference
• GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.

  2000cited by this paper
• Vanilloid receptors on capsaicin‐sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries

  2000cited by this paper
• Cannabinoid and kappa opioid receptors reduce potassium K current via activation of G(s) proteins in cultured hippocampal neurons.

  2000cited by this paper
• Cannabinoid receptor‐mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes

  2000cited by this paper
• 2-Arachidonoylglycerol and the cannabinoid receptors.

  2000cited by this paper
• Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo.

  2000influential reference
• Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study.

  2000cited by this paper
• Electrically Evoked Release of [3H]Noradrenaline from Mouse Cultured Sympathetic Neurons

  2000cited by this paper
• Endocannabinoids as cardiovascular modulators.

  2000cited by this paper
• Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice.

  2000cited by this paper
• Sensitive determination of anandamide in rat brain utilizing a coupled-column HPLC with fluorimetric detection.

  2000cited by this paper
• Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells.

  2000cited by this paper
• Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons.

  2000cited by this paper
• Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study.

  2000cited by this paper
• Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations

  2000cited by this paper
• Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development

  2000cited by this paper
• Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea‐pig ileum

  2000cited by this paper
• Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

  2000cited by this paper
• Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease

  2000influential reference
• Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice

  2000cited by this paper
• The anandamide transport inhibitor AM404 activates vanilloid receptors.

  2000cited by this paper
• Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.

  2000cited by this paper
• Reversal of Dopamine D2 Receptor Responses by an Anandamide Transport Inhibitor

  2000influential reference
• Cannabinoid receptors and the regulation of immune response.

  2000cited by this paper
• Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2*

  2000cited by this paper
• The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes.

  2000cited by this paper
• Mechanisms of Cannabinoid Inhibition of GABAASynaptic Transmission in the Hippocampus

  2000cited by this paper
• Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin‐like activity

  2000cited by this paper
• Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons.

  2000cited by this paper
• The fatty acid amide hydrolase (FAAH).

  2000cited by this paper
• Structure—Activity Relationships Among N‐Arachidonylethanolamine (Anandamide) Head Group Analogues for the Anandamide Transporter

  2000cited by this paper
• Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system

  2000cited by this paper
• Modulation of (3)H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and beta-adrenoceptors in mouse tissues.

  2000cited by this paper

• Discovery of reversible monoacylglycerol lipase (MAGL) inhibitors based on ortho-hydroxyanilide scaffold.

  2025cites this paper
• CÁRIE DENTAL E O POTENCIAL PREVENTIVO DOS CANABINOIDES

  2025cites this paper
• Is There a Place for Cannabinoids in Asthma Treatment?

  2025cites this paper
• Association of cannabis use with female infertility based on NHANES

  2025cites this paper
• Identification and experimental validation of biomarkers associated with the endocannabinoid system in major depressive disorder

  2025cites this paper
• Effect of intraperitoneal cannabidiol (CBD) injection on intestine microbiome profile in a mouse model

  2025cites this paper
• UK Medical Cannabis Registry: An Analysis of Clinical Outcomes of Medicinal Cannabis Therapy for Cancer Pain

  2025cites this paper
• Transcriptomic Alterations Induced by Tetrahydrocannabinol in SIV/HIV Infection: A Systematic Review

  2025cites this paper
• Enhancing Tetrahydrocannabinol’s Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011

  2025cites this paper
• Cannabinoid receptors in GtoPdb v.2025.1

  2025cites this paper
• Substrate-selective COX-2 inhibition by IMMA attenuates posttraumatic headache via endocannabinoid modulation and neuroinflammatory suppression

  2025cites this paper
• Molecular Mechanisms of the Endocannabinoid System with a Focus on Reproductive Physiology and the Cannabinoid Impact on Fertility

  2025influential citation
• Palmitoylethanolamide (PEA) Induces an Increase in Spleen Regulatory T Cells, Reduces CD8 + Cells and TNF‐α Levels in Target Organs, and Protects Mice From Graft‐Versus‐Host Disease‐Related Mortality Through PPAR Activation Without Compromising the Graft‐Versus‐Tumour Response

  2025cites this paper
• Applications of Cannabinoids in Neuropathic Pain: An Updated Review.

  2024cites this paper
• Liver Transcriptomic Profiles of Ruminant Species Fed Spent Hemp Biomass Containing Cannabinoids

  2024cites this paper
• Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation

  2024cites this paper
• Tetrahydrocannabinol and dopamine D1 receptor

  2024cites this paper
• Insight into the mechanism of action of ORG27569 at the cannabinoid type one receptor utilising a unified mathematical model

  2024cites this paper
• Interplay between cannabinoids and the neuroimmune system in migraine

  2024cites this paper
• Causal effects of genetically determined blood metabolites on asthma: a bidirectional Mendelian randomization study

  2024cites this paper
• Cannabinoids and triple-negative breast cancer treatment

  2024cites this paper
• Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol

  2024cites this paper
• 2-AG-loaded and bone marrow-targeted PCL nanoparticles as nanoplatforms for hematopoietic cell line mobilization

  2024cites this paper
• The Role of Fatty Acid Amide Hydrolase, a Key Regulatory Endocannabinoid Enzyme, in Domain-Specific Cognitive Performance in Psychosis

  2024cites this paper
• Connections between Endometrial Health Status, Fatty Liver and Expression of Endocannabinoid System Genes in Endometrium of Postpartum Dairy Cows

  2024cites this paper
• Stereoisomers of cannabidiols and their pharmacological activities - A potentially novel direction for cannabinoids.

  2024cites this paper
• Cannabidiol enhances socially transmitted food preference: a role of acetylcholine in the mouse basal forebrain

  2024cites this paper
• CBD’s potential impact on Parkinson’s disease: An updated overview

  2024cites this paper
• Selective blockade of cannabinoid receptors influence motoneuron survival and glial reaction after neonatal axotomy.

  2024cites this paper
• An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects

  2024influential citation
• Characterization of binding kinetics and intracellular signaling of new psychoactive substances targeting cannabinoid receptor using transition-based reweighting method

  2023influential citation
• Transition-based reweighting and neural rational inference analysis of effects of new psychoactive substances on cannabinoid receptors

  2023cites this paper
• Altered endocannabinoid metabolism compromises the brain-CSF barrier and exacerbates chronic deficits after traumatic brain injury in mice.

  2023cites this paper
• Participation of the cannabinoid system and the NO/cGMP/KATP pathway in serotonin-induced peripheral antinociception.

  2023cites this paper
• Underlying mechanisms of long-term potentiation during the inhibition of the cannabinoid CB1 and GABAB receptors in the dentate gyrus of hippocampus

  2023cites this paper
• CBD lengthens sleep but shortens ripples and leads to intact simple but worse cumulative memory

  2023cites this paper
• Cannabidiol as a Modulator of the Development of Alcohol Tolerance in Rats

  2023cites this paper
• Cannabinoid receptors in GtoPdb v.2023.1

  2023cites this paper
• Effect of Tetrahydrocannabinol on Dopamine Through CB1 Receptor

  2023cites this paper
• CBD lengthens sleep, shortens ripples and leads to intact simple but worse cumulative memory

  2023cites this paper
• Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry

  2023cites this paper
• Pharmacological blockade of cannabinoid receptor 2 signaling does not affect LPS/IFN-γ-induced microglial activation

  2023cites this paper
• Cannabinoid CB2 receptors modulate alcohol induced behavior, and neuro-immune dysregulation in mice.

  2023cites this paper
• Discovery of 1,3-disubstituted pyrazole peripheral cannabinoid receptor partial agonists.

  2023cites this paper
• Molecular and Cellular Mechanisms of Action of Cannabidiol

  2023cites this paper
• Mechanism of Action of Tibial Nerve Stimulation in the Treatment of Lower Urinary Tract Dysfunction.

  2023cites this paper
• How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases

  2023cites this paper
• Cannabidiol Reduces Systemic Immune Activation in Experimental Acute Lung Injury

  2023cites this paper
• Cannabinoid receptor gene CNR1 is downregulated in subcortical brain samples and upregulated in blood samples of individuals with schizophrenia: A participant data systematic meta‐analysis

  2023cites this paper
• Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation

  2023cites this paper
• In Vitro Characterization of 6-Methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl-1H-indole (ZCZ011) at the Type 1 Cannabinoid Receptor: Allosteric Agonist or Allosteric Modulator?

  2022cites this paper
• Overview of the Endocannabinoid System and Endocannabinoidome

  2022cites this paper
• “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained

  2022cites this paper
• Symposium review: Adipose tissue endocrinology in the periparturient period of dairy cows.

  2022cites this paper
• Considerations for Cannabinoids in Perioperative Care by Anesthesiologists

  2022cites this paper
• Between Science and Big Business: Tapping Mary Jane’s Uncharted Potential

  2022cites this paper
• Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review

  2022cites this paper
• Role of classical cannabinoid receptors in cancer-associated bone disease

  2022cites this paper
• Distinct activation mechanisms regulate subtype selectivity of Cannabinoid receptors

  2022cites this paper
• PUFA-Derived N-Acylethanolamide Probes Identify Peroxiredoxins and Small GTPases as Molecular Targets in LPS-Stimulated RAW264.7 Macrophages

  2022cites this paper
• THE INFLUENCE OF ENDOCANNABINOID SYSTEM ON WOMEN REPRODUCTION.

  2022cites this paper
• Structural insight into the constitutive activity of human orphan receptor GPR12.

  2022cites this paper
• Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation

  2022influential citation
• Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders

  2022cites this paper
• CD4+-mediated colitis in mice is independent of the GPR183 and GPR18 pathways

  2022cites this paper
• Inhibiting Fatty Acid Amide Hydrolase Ameliorates Enteropathy in Diabetic Mice: A Cannabinoid 1 Receptor Mediated Mechanism

  2022cites this paper
• Curcumin induces peripheral antinociception by opioidergic and cannabinoidergic mechanism: Pharmacological evidence.

  2022cites this paper
• Clinical Evidence of Cannabinoids in Migraine: A Narrative Review

  2022cites this paper
• Dietary fatty acids modulate the endocannabinoid system in rat submandibular gland

  2022cites this paper
• Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives

  2022cites this paper
• Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy

  2022cites this paper
• Evidence-based Potential Therapeutic Applications of Cannabinoids in Wound Management

  2022cites this paper
• New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders

  2022cites this paper
• Involvement of CB2 signalling pathway in the development of osteoporosis by regulating the proliferation and differentiation of hBMSCs

  2021cites this paper
• Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues.

  2021cites this paper
• Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders.

  2021cites this paper
• Integrating Endocannabinoid Signalling In Depression

  2021cites this paper
• Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial

  2021cites this paper
• Parkinson's Disease related alterations in cannabinoid transmission.

  2021cites this paper
• Overview of Medicinal Cannabis

  2021cites this paper
• Effects of endocannabinoids on feed intake, stress response and whole-body energy metabolism in dairy cows

  2021cites this paper
• Gamma-Aminobutyric Acid (GABA) and the Endocannabinoids: Understanding the Risks and Opportunities

  2021cites this paper
• Cannabinoids as anticancer and neuroprotective drugs: Structural insights and pharmacological interactions—A review

  2021cites this paper
• Cannabis e Câncer de mama: Evidências com células in vitro

  2021cites this paper
• Neuropathology of Drug Abuse

  2021cites this paper
• Medical Cannabis in Palliative Psychiatry: Clinical Aspects of Affective Regulation and Legal Challenges

  2021cites this paper
• Monoacylglycerol lipase (MAGL) inhibitors based on a diphenylsulfide-benzoylpiperidine scaffold.

  2021cites this paper
• Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors

  2021cites this paper
• Cannabis-Induced Neuroactivity: Research Trends and Commercial Prospects

  2021cites this paper
• Evaluation of the Expression Levels of Cannabinoid Type-1 (CB1) Receptor and Phosphorylated Extracellular Signal-Regulated Kinase (p-ERK) in Gliomas

  2021cites this paper
• Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System—Implications for Health and Disease

  2021cites this paper
• Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies

  2021cites this paper
• The Endocannabinoid, Anandamide, Acts as a Novel Inhibitor of LPS‐Induced Inflammasome Activation in Human Gastric Cancer AGS Cell Line: Involvement of CB1 and TRPV1 Receptors

  2021cites this paper
• Thc-You Later Chronic Pain?

  2021cites this paper
• Why does Δ9-Tetrahydrocannabinol act as a partial agonist of cannabinoid receptors?

  2021cites this paper
• Endocannabinoid System and Its Regulation by Polyunsaturated Fatty Acids and Full Spectrum Hemp Oils

  2021cites this paper
• Endocannabinoid System Components as Potential Biomarkers in Psychiatry

  2020cites this paper
• Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia

  2020cites this paper
• CB2 Agonist (AM1241) Improving Effect on Ovalbumin-Induced Asthma in Rats

  2020cites this paper
• Developing Raman microspectroscopy as a technique to analyse single Caco-2 cell

  2020cites this paper